Company Description

Since its inception Manhattan Scientifics Inc. has been a technology developer that nurtures financially promising technologies with potential global commercial applications.

Manhattan Scientifics has enjoyed a “Special informal relationship” and a lengthy successful history in tech-transfer from the Los Alamos National Laboratory (LANL) and the Sandia National Laboratory (SNL).

An example of this relationship was the seed funding and launch of Novint Technologies, which acquired the exclusive, perpetual, global license to the Haptics touch technology from SNL and now trades as a listed company in the USA. http://www.novint.com. (OTC BB; NVNT).

Technologies

Advanced Materials

The scientists and engineers at MHTX are applying the power of physics nanotechnology (Materials Science) to metals, promising to reduce their weight by 25% while doubling their strength TODAY. MHTX believes this will result in a reduction in the consumption of both materials, energy and the resources used to produce them: a virtuous circle of less consumption and more strength. In other words, MHTX is a solution to concerns about mounting strain on the globe’s natural resources.

Nanomedicine

Manhattan Scientifics acquired the exclusive commercial rights (manufacturing and marketing) to Edward R. Flynn's (president and CEO of Senior Scientific, LLC) patents and IP in the emerging field of nano medicine; specifically Dr. Flynn's work in biomagnetic detection of cancer and other diseases through magnetic field sensors. These sensors make it possible to identify and image small clusters of cancer cells substantially increasing the sensitivity for finding cancer at an earlier stage than is currently available, and without the use of ionizing radiation or large magnetic fields. The biomagnetic sensor method is applicable to breast, ovarian, leukemia, prostate, melanoma, and other cancers. Dr. Flynn's research has been funded by the National Institute of Health (NIH). Management intends to identify one or more appropriate Fortune/500 industrial partners in the Big Pharma group to bring product to the market under royalty bearing licenses.

Technology And Background

Manhattan Scientifics began as a technology incubator. Early in its history it worked on acquiring several technologies in the fields of holographic data storage, water purification, alternative energy, advanced computer haptics and now, nanotechnology. Its primary source of latent commercial technologies are the US government laboratories in New Mexico.

During the nasdaq bubble in year 2000, Manhattan Scientifics had a market capitalization approaching $900 million, about 60 times the company’s present market cap, despite the fact that the companies intrinsic value is worth many times more today than it was in year 2000.

Key Company Developments

• Manhattan Scientifics and Senior Scientific File Provisional Patent on Early Cancer Detection System
• Manhattan Scientifics Signs LOI to Acquire Rights to Early Cancer Detection System Developed by Dr. Edward R. Flynn
• Manhattan Scientifics, Inc. Announces Exclusive License with Carpenter Technology Corporation
• Manhattan Scientifics and Los Alamos National Laboratory Sign Licensing Partnership Agreement
• FDA Approval Granted on New Titanium Dental Implant
• Manhattan Scientifics Appoints Professor Henry J. Rack, Prominent Material Scientist to Its Research Team
• Manhattan Scientifics Acquires Metallicum, Inc.
• Art Kaufman to Join Manhattan Scientifics Science and Technology Committee
• Manhattan announced a Letter of Intent to acquire Metallicum Inc.
• Manhattan announced its new CEO, Emmanuel (Manny) Tsoupanarias
• Manhattan acquired 43 Million MHTX common shares from the Lancer Fund Trustee. Company raised $1.1 million in private placement of equity.
• Manhattan raised new capital and new management to re-start operations.

Media Over View Click Here

Company History

The story of Manhattan Scientifics begins with the holographic research component of the Company. In the late 1980s the Microelectronics & Computer Corporation (MCC), invested approximately $25 million in holographic data storage research.

The research produced no conclusive results. However, Manhattan Scientifics CEO, Marvin Maslow, fascinated by the potential of holographic storage, was reluctant to give up, believing that eventually, its time would come. He decided a more intense and focused research effort, with new expertise, might eventually produce the long-sought results.

Meanwhile, in August 1997 Maslow visited Los Alamos National Laboratory (LANL) to investigate new technologies with commercialization potential. LANL's Civilian Industrial Technology Program Office, functioning in the capacity of matchmaker, introduced Maslow to Robert Hockaday, a LANL physicist who had taken entrepreneurial leave-of-absence to refine a patented MicroFuel Cell technology he had been developing with his own funds. Maslow recognized that the holographic project might benefit from the expertise of Los Alamos National Laboratory materials science experts, and, combined with the MicroFuel Cell technology, would be a solid foundation for a technology incubator to commercialize leading-edge technologies.

Knowing that fledgling companies can flounder during the standard capitalization process of protracted analysis and negotiations, and that getting a new technology to market quickly is crucial to success, Maslow deployed what he calls a "guerrilla financing" strategy. In a period of approximately four months he formed Manhattan Scientifics, Inc., raised the capital Hockaday estimated he needed to begin intensive development of a working prototype, and took the Company public on January 9, 1998 by means of a reverse merger.

Nano Titanium

Manhattan Scientific’s nanostructured metal technology is based on over 16 years of highly focused research and development. Nanostructured metals and alloys possess significantly enhanced  mechanical properties that include, for example, increased strength without concurrent losses in ductility, and significantly increased resistance to fatigue fracture. Nanostructured commercially pure grades of titanium have proven to also possess excellent machinability as well as high toughness and strength. Manhattan Scientifics has developed unique processing methodology for producing nanostructures in a wide range of ductile metals and alloys and is now commercializing this new and revolutionary technology.

Enhanced strength and fatigue resistance

Nanostructured metals and alloys offer many advantages for a wide range of structural applications. Application areas include biomedical structures, sports structures, aerospace and chemical structures, among others.

Contact Information

Corporate Offices
The Chrysler Building, 26th Floor
405 Lexington Avenue
New York, NY 10174

Tel. :             (212) 541-2405      
Fax. : (917) 368-8005

Email : info@manhattan-scientifics.com

Emmanuel (Manny) Tsoupanarias
Chief Executive Officer

Tel. :             (918) 919-0370      

Email : mtsoupanarias@manhattan-scientifics.com

Our Locations

 Company website: http://www.mhtx.com/

United States of America

The Chrysler Building, 26th Floor
405 Lexington Avenue
New York, NY 10174

New Mexico
800 Bradbury SE, Suite 213,
Albuquerque, NM, 87106

For inquiries from Media

Stanton Public Relations & Marketing
880 Third Avenue
New York, NY 10022
Tel:             (646) 502-3528      

Website: http://www.stantonPRM.com

PRESS RELEASES

http://www.otcmarkets.com/stock/MHTX/news

SHARE STRUCTURE: (as of May 1, 2011, per 10Q SEC Filing):
Authorized Shares: 500 million
Issued & Outstanding: 412,769,926
Float: 337 million (per Investor Relations Business Profile (PDF Download): http://www.hawkassociates.com/clients/profile/?client_id=7)

Daily Chart ~